AMARILLO, Texas (AP) — A federal ... Judge Matthew Kacsmaryk is weighing a lawsuit from Christian conservatives aimed at overturning the Food and Drug Administration's more than 2-decade-old ...

Mifepristone was authorized by the U.S. Food and Drug Administration in 2000. In the U.S., the drugs are approved up to 10 weeks' gestation, although the World Health Organization says they can be ...

For about four hours of arguments, a federal judge in Texas asked questions that suggested he is seriously considering undoing the US Food and Drug Administration’s approval of a medication ...

Court officials in Amarillo, Texas, have released the transcript from this week's closely watched hearing in a federal lawsuit that could curb access nationwide to a drug that's used in nearly all ...

Kacsmaryk did not make a decision during the hearing in Amarillo, Texas, ... by targeting the decadeslong Food and Drug Administration approval of the drug mifepristone. ...

The Supreme Court sent the case back to Amarillo. Those suing want to alter their suit while the Food and Drug Administration and the Department of Health and Human Services are asking Judge ...

AMARILLO, Tex. — The federal judge who could upend access to a key abortion medication seemed open on Wednesday to the argument that the drug had not been properly vetted and could be unsafe ...

AMARILLO, Texas (KAMR/KCIT) – Amarillo Police Proactive Criminal Enforcement officers and Drug Enforcement Administration agents recently arrested a man accused of drug trafficking who has ...

A group of anti-abortion doctors filed a lawsuit to revoke the Food and Drug Administration’s approval of mifepristone, which the U.S. Supreme Court ultimately rejected.

For example, the food additive azodicarbonamide, known as ADA and used as a bleaching agent in cereal flours, is included on ...

The Department of Justice on Monday said a lawsuit against the Food and Drug Administration seeking to sharply restrict the abortion pill mifepristone should be dismissed, continuing the position ...

HOUSTON, Texas (KTRK) -- The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The ...